Exploring Addiction Medicine and Reproductive Health Advocacy

The chapter delves into a conversation with a 55-year-old woman who transitioned from reproductive health advocacy to addiction medicine, emphasizing the importance of training professionals in various fields and stepping into roles where societal help is needed. It explores the intersection of addiction medicine and reproductive health advocacy, discussing a case of a 32-year-old woman with severe opioid use disorder and the differences between methadone and buprenorphine in treating opioid addiction, especially in the context of fentanyl use.